A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 9/20 (2006.01) A61K 31/35 (2006.01)
Patent
CA 2732093
A controlled release pharmaceutical composition comprises (a) topiramate or a pharmaceutically acceptable salt thereof, (b) a first intelligent polymer component; and (c) a second intelligent polymer component having opposite wettability characteristics to the first intelligent polymer component. The polymer components are effective for controlled release of the pharmaceutically active substance from the composition.
L'invention porte sur une composition pharmaceutique à libération contrôlée qui comprend (a) du topiramate ou un sel pharmaceutiquement acceptable de celui-ci, (b) un premier composant polymère intelligent; et (c) un second composant polymère intelligent ayant des caractéristiques de mouillabilité opposées au premier composant polymère intelligent. Les composants polymères sont efficaces pour une libération contrôlée de la substance pharmaceutiquement active à partir de la composition.
Jackson Graham
Nghiem Tien
Bereskin & Parr Llp/s.e.n.c.r.l.,s.r.l.
Biovail Laboratories International Srl
Valeant International (barbados) Srl
LandOfFree
Controlled release formulations using intelligent polymers does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Controlled release formulations using intelligent polymers, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Controlled release formulations using intelligent polymers will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1399318